Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Pemetrexed × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 54 Lung Neoplasms 27 Neoplasm Metastasis 8 Neoplasms 7 Colorectal Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Carcinoma 4 Rectal Neoplasms 3 Mesothelioma, Malignant 3 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Pancreatic Neoplasms 2 Non-Squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 Lung Diseases 2 Carcinoma, Pancreatic Ductal 2 Carcinoma, Bronchogenic 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumor, Pleural 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Recurrence 1 Pathologic Processes 1 Pathologic Complete Response 1 Ovarian Neoplasms 1

Interventions

Cyclophosphamide 12 Rituximab 11 obinutuzumab 9 fludarabine 9 Prednisone 7 ibrutinib 6 Lenalidomide 6 tocilizumab 5 fludarabine phosphate 5 Biopsy 5 venetoclax 4 pirtobrutinib 4 glofitamab 4 Specimen Handling 4 Doxorubicin 4 polatuzumab vedotin 3 X-Rays 3 Vincristine 3 Phantoms, Imaging 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 tucatinib 2 temsirolimus 2 pertuzumab 2 palbociclib 2 olaparib 2 cobimetinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Trastuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡